
UiPath Inc (PATH)
NEW YORK STOCK EXCHANGE, INC. · Technology · USD
Consenso analisti
Cosa significano questi rating?28 analisti: 3 Strong Buy · 5 Buy · 18 Hold · 2 Sell.
Target price analisti
Target price non disponibile per questo titolo.
Statistiche chiave
Fondamentali e dati di trading aggiornati. Fonte: Finnhub.
Notizie sul titolo
Nvidia’s sudden CEO vacuum and the recent 10% slide in its share price have rattled expectations around cheap, abundant AI compute, yet that shock also throws a spotlight on which enterprises can absorb higher infrastructure costs without breaking their business models. Investors who ignore this shift risk missing where resilience could build next. This article unpacks three stocks exposed to that Nvidia news, all drawn from our AI Cost-Resilient Enterprise Software and Cloud Platforms...
Recently, Zacks.com users have been paying close attention to UiPath (PATH). This makes it worthwhile to examine what the stock has in store.
Fastly grew revenue 14.8% but still lost money, while UiPath swung to a $282 million profit and trades at a lower forward P/E.
Alphabet just invested in Qualcomm for the first time ever.
UiPath announced it is a launch partner for Google Cloud’s Gemini for healthcare, connecting Gemini to UiPath automations through the Model Context Protocol Server so regulated healthcare providers can run governed, end to end workflows across multiple systems. The integration positions UiPath closer to high stakes, compliance heavy healthcare workloads, where its governance, permissions and audit controls are central to how AI agents and robots execute work. The next area of focus is how...
UiPath (PATH) is back in focus after being named a launch partner for Google Cloud’s Gemini for healthcare, tying its automation platform directly into Gemini powered clinical and operational workflows. Recent price action tells a more cautious story. At a latest share price of $12.83, UiPath’s stock has declined over the past month and is down 19.21% on a year to date share price return. The 5 year total shareholder return has fallen 77.07%, suggesting long term holders have seen momentum...
UiPath has tied its automation platform more tightly to large scale artificial intelligence, while the share price has fallen sharply over several years, so the key issue for you is whether the current valuation still lines up with the cash that the business is expected to generate. The stock has fallen 77.1% over 5 years, which puts the focus squarely on whether the market is now pricing UiPath’s future cash flows more conservatively than before. Recent partnerships like the integration...
Oddity Tech (ODD) delivered earnings and revenue surprises of +23.33% and +2.64%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Informazioni su UiPath Inc
UiPath Inc è quotata su NEW YORK STOCK EXCHANGE, INC. con il ticker PATH e opera nel settore Technology. La capitalizzazione di mercato è di circa 6,85 miliardi di dollari.
Il consenso corrente degli analisti su PATH è Hold, calcolato su 28 giudizi: 3 Strong Buy, 5 Buy, 18 Hold, 2 Sell e 0 Strong Sell.
PATH tratta a un rapporto prezzo/utili (P/E) di 18,92. L'utile per azione degli ultimi dodici mesi è di 0,67 di dollari. Nelle ultime 52 settimane il titolo si è mosso tra 9,20 e 19,84 di dollari.
Questa pagina raccoglie la quotazione in tempo reale di PATH, il grafico storico da 1 giorno a 5 anni, il target price medio degli analisti, i principali indicatori fondamentali (P/E, capitalizzazione, margini, crescita, indebitamento) e le ultime notizie sulla società. I prezzi sono consultabili in cinque valute.
Altri titoli Software e Cloud →Cosa significano questi rating?
Titoli correlati · Software e Cloud
Solo scopo informativo. NON è consulenza finanziaria né raccomandazione di investimento (D.Lgs. 58/1998). I giudizi mostrati sono il consenso medio aggregato di analisti terzi via Finnhub. Vedi note legali. Note legali